RxDoctor Payments Data

Walter Schroeder, MD

Otolaryngology · Henderson, NVNPI 1205892650

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.9% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations.

$4,335in general payments, 2019–2025

Across 162 payments — averaging $26.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$976
  • Intersect ENT, Inc.$729
  • Regeneron Healthcare Solutions, Inc.$700
  • Optinose US, Inc.$547
  • Stryker$490
  • Sanofi$302
  • plus $591 from 14 others

What the payments were for

  • Travel & lodging$752%
  • Food & beverage$4,11395%
  • Education$1473%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,335 in reported general payments places this provider in the 70th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada

Medicare billing

Part B allowed, 2024
$81,756
Medicare patients
279
Services billed
758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin23$2,382
Fluticasone Propionate42$666
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$388
Ipratropium Bromide15$302
Cephalexin35$198
Methylprednisolone25$150
Azithromycin16$61

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →